Polymer Capital Management (Us) LLC Iovance Biotherapeutics, Inc. Transaction History
Polymer Capital Management (Us) LLC
- $846 Billion
- Q2 2025
A detailed history of Polymer Capital Management (Us) LLC transactions in Iovance Biotherapeutics, Inc. stock. As of the latest transaction made, Polymer Capital Management (Us) LLC holds 62,699 shares of IOVA stock, worth $140,445. This represents 0.01% of its overall portfolio holdings.
Number of Shares
62,699
Previous 55,582
12.8%
Holding current value
$140,445
Previous $185 Million
41.73%
% of portfolio
0.01%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding IOVA
# of Institutions
293Shares Held
233MCall Options Held
1.14MPut Options Held
1.15M-
Mhr Fund Management LLC New York, NY29MShares$64.9 Million8.78% of portfolio
-
Vanguard Group Inc Valley Forge, PA25.1MShares$56.2 Million0.0% of portfolio
-
Black Rock Inc. New York, NY21.2MShares$47.5 Million0.0% of portfolio
-
Long Focus Capital Management, LLC San Juan, PR11.8MShares$26.5 Million0.94% of portfolio
-
State Street Corp Boston, MA9.89MShares$22.2 Million0.0% of portfolio
About IOVANCE BIOTHERAPEUTICS, INC.
- Ticker IOVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 157,800,992
- Market Cap $353M
- Description
- Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...